Lassa Fever
NIH launches trial of Lassa fever vaccine
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
Top in ID: Iowa resident dies of Lassa fever; mpox boosters may be needed
An Iowa resident died of Lassa fever after returning home from travel to West Africa, according to Iowa health officials.
Iowa resident dies of Lassa fever after returning from West Africa, officials say
An Iowa resident who traveled to West Africa has died of Lassa fever after returning home, Iowa health officials said.
Top in ID: Experts seek rapid tests for deadly viruses; doxy-PEP shows potential for STIs
The Coalition for Epidemic Preparedness Innovation, or CEPI, is spending $14.9 million to develop rapid tests for Nipah virus and Lassa fever.
Scientists pursue on-the-spot rapid tests for Nipah virus, Lassa fever
The Coalition for Epidemic Preparedness, or CEPI, is funding a project to develop on-the-spot rapid tests for Nipah virus and Lassa fever to better monitor outbreaks of both diseases, the organization announced.
Patients with Ebola virus, Lassa fever can be treated without infecting health care personnel
“Meticulous” implementation of infection control and clinical biosafety practices enable health care staff to treat patients infected with Ebola virus disease and Lassa fever without causing occupation-related symptomatic or asymptomatic infection, according to a study conducted in the Serious Communicable Diseases Unit at Emory University.